Contract Services

Four decades delivering contract pharma solutions for our partners

Alkermes Contract Pharma Services provides solid dosage form product development, formulation solutions and manufacturing services for the pharmaceutical market. We have a long and successful history in the development and manufacture of pharmaceutical dosage forms for pharmaceutical markets worldwide. We have a blue chip list of partners and have assisted in the successful launch of multiple products in more than 100 countries in North America, Europe and Asia.

Extensive development, scale-up and manufacturing capabilities in U.S. and Europe

We offer a complete range of pharmaceutical development and manufacturing capabilities to support your requirements including effective, robust and swift tech transfers, a full selection of proven and validated technology and process improvement solutions, competitive pricing, on time delivery with an exceptional compliance track record in FDA/EMA licensed sites in U.S. and EU. Since we began pioneering drug development solutions for the pharma industry, over 40 years ago, we have assisted in the development and launch of over 40 products in the U.S. and International markets. 

Modern Facilities to fit Partners Precise Product Requirements

Alkermes Contract Pharma Services offers a significant advantage in outsourcing – a broad range of services and expertise integrated into one company – based in the U.S. and Europe. This approach reduces the need for technical transfers from product development and clinical trial suppliers to commercial manufacturing sites, enabling efficient scale-up from formulation to commercial production. By providing the whole process in this integrated manner, we have been able to recommend ways to improve production methods – reducing partner risk and also improving efficiencies.

Capabilities and Facilities

• Dedicated formulation, development, scale-up and commercial manufacturing
• Modern facilities in Europe and U.S.
• Development and tech transfer capabilities
• Formulation through scale-up and full scale manufacturing
• 2.5 billion units annually in solid oral dosage form manufacturing capacity
• 270,000sq ft of cGMP manufacturing  facilities 
• Excellent compliance record
• Packaging facilities U.S. and Ireland
• Mature infrastructure
• DEA approved controlled substance manufacturing plant in U.S. 
• Develops and manufactures product for U.S., European, and Japanese markets as well as the emerging markets of India, China and Brazil

For more information on our range and depth of capabilities click here.

For more information on the integrated approach of our production model, click here.